Prevalence and Factors Associated With Atrial Fibrillation in Patients With Type 2 Diabetes

Burapha University

Status: Completed

Conditions: Atrial Fibrillation; Type 2 Diabetes

Treatments: Other: Routine examinations

Study type: Observational

Funder types: Other

Identifiers

NCT06174129

HS114/2565

Details and patient eligibility

About

This case-control study was conducted at Burapha University Hospital. The 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.

Enrollment: 427 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Outpatients with type 2 diabetes who visited the medical clinic between June 2022 and June 2023

Exclusion criteria

• Patients with missing information on the urinary albumin value and electrocardiograms at the latest date

Trial design

427 participants in 2 patient groups

Type 2 diabetes patients with atrial fibrillation

Description:

The 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.

Treatment:

Other: Routine examinations

Type 2 diabetes patients without atrial fibrillation

Description:

The 12-lead electrocardiography recordings of type 2 diabetes patients were reviewed by a cardiologist to confirm the presence of atrial fibrillation. The clinical parameters, including age, sex, body-mass index, underlying medical conditions, blood pressure, heart rate, type 2 diabetes duration, laboratory values, and medications were analyzed and compared between atrial fibrillation and non-atrial fibrillation patients.

Treatment:

Other: Routine examinations